PMID: 7931890Oct 1, 1994Paper

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

The Journal of Pediatrics
J A EnglundP Hiatt


Children with suspected respiratory syncytial virus infection were examined prospectively in a randomized evaluation of standard ribavirin aerosol therapy (6 gm/300 ml water for 18 hours daily) compared with high-dose, short-duration ribavirin aerosol therapy (6 gm/100 ml water given for a period of 2 hours three times a day) by means of an oxygen hood (n = 20) or a ventilator (n = 12). Viral shedding was quantitated daily; clinical observations were recorded daily by 2 physicians aware and one unaware of treatment assignments. Study characteristics evaluated at entry were not significantly different in the high-dose and the standard-dose groups. Viral titers and clinical scores decreased similarly in both groups during the study; pulmonary function test results were also similar at discharge in children not receiving mechanical ventilation. Potential complications related to aerosol therapy were noted in three patients (one hood patient who was receiving standard therapy; two patients with an endotracheal tube in place who were receiving high-dose therapy); substantial crystallization was noted in the tubing of the patients undergoing intubation and receiving high-dose therapy. Environmental sampling revealed that ribavirin wa...Continue Reading


Mar 1, 1991·The Pediatric Infectious Disease Journal·A TorresP L Havens

❮ Previous
Next ❯


Oct 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G Mlinaric-GalinovicE E Walsh
Jun 1, 2001·Current Infectious Disease Reports·Leonard R. Krilov
Dec 18, 2003·Clinics in Dermatology·Peggy LinStephen K Tyring
Mar 17, 1997·The American Journal of Medicine·E WhimbeyR B Couch
Sep 7, 2000·Diagnostic Microbiology and Infectious Disease·G Mlinaric-Galinovic, D Varda-Brkic
Aug 1, 1996·International Journal of Antimicrobial Agents·E De Clercq
Sep 1, 1996·Acta Anaesthesiologica Scandinavica·B WåhlinL G Hellström
Oct 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Samson S Y Wong, Kwok-Yung Yuen
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·A M GuerguerianJ Lacroix
Jul 25, 2003·Expert Opinion on Pharmacotherapy·Federico Martinón-Torres
Mar 30, 2010·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J González de DiosUNKNOWN Grupo de Revisión del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad y Adecuación)
Feb 19, 2008·Antiviral Research·Brian E Gilbert, Matthew T McLeay
Aug 1, 1997·Expert Opinion on Investigational Drugs·N J Snell
Nov 22, 2005·Expert Opinion on Drug Delivery·Ursa GlabermanClaire F Verschraegen
Oct 5, 2001·Expert Opinion on Pharmacotherapy·N J Snell
Jan 18, 2003·Paediatric Respiratory Reviews·D Hodge, P A Chetcuti
Jan 14, 2000·The Journal of Hospital Infection·B L JonesJ Hood
Mar 26, 2005·Canadian Journal of Physiology and Pharmacology·Gordon BolgerMichel Liuzzi
Mar 1, 1996·The Pediatric Infectious Disease Journal·P C RimensbergerU B Schaad
Aug 2, 2002·The Pediatric Infectious Disease Journal·Leonard R Krilov
May 14, 2010·The Cochrane Database of Systematic Reviews·Kathleen Ventre, Adrienne Randolph
Feb 24, 2001·Annals of the New York Academy of Sciences·C F VerschraegenB E Gilbert
Jan 9, 2019·Frontiers in Microbiology·Diego R HijanoRandall T Hayden
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Philip R. Wyde

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.